| Impaired Fasting Glucoseab | Known DM | New DMa | New and Known DMa | ||||
---|---|---|---|---|---|---|---|---|
 | National estimatec | Prevalence (95% CI) | National estimatec | Prevalence (95% CI) | National estimatec | Prevalence (95% CI) | National estimatec | Prevalence (95% CI) |
Age | Â | Â | Â | Â | Â | Â | Â | Â |
   25–34 (n = 843) | 0.6 | 5.1 (3.4–7.6) | 0.1 | 0.7 (0.3–1.5) | 0.3 | 2.5 (1.4–4.4) | 0.4 | 3.2 (2.0–5.0) |
   35–44 (n = 902) | 0.9 | 10.0 (7.6–13.0) | 0.4 | 4.9 (3.3–7.3) | 0.4 | 4.3 (3.2–5.8) | 0.8 | 9.2 (7.0–12.1) |
   45–54 (n = 869) | 0.9 | 13.6 (11.5–16.1) | 0.5 | 8.4 (6.7–10.4) | 0.4 | 5.6 (3.5–8.7) | 0.9 | 14.0 (11.2–17.3) |
   55–64 (n = 783) | 0.5 | 14.6 (11.9–17.9) | 0.4 | 12.1 (8.2–17.4) | 0.2 | 6.7 (4.9–9.1) | 0.6 | 18.8 (14.7–23.6) |
Sex | Â | Â | Â | Â | Â | Â | Â | Â |
   Males (n = 1645) | 1.5 | 9.3 (7.7–11.3) | 0.7 | 4.4 (3.1–6.1) | 0.6 | 4.0 (3.1–5.2) | 1.3 | 8.4 (6.6–10.5) |
   Females (n = 1752) | 1.4 | 9.0 (7.2–11.3) | 0.8 | 4.9 (3.8–6.2) | 0.7 | 4.2 (2.9–6.0) | 1.4 | 9.1 (7.4–11.2) |
Residential area | Â | Â | Â | Â | Â | Â | Â | Â |
   Urban (n = 2175) | 2.1 | 9.8 (8.3–11.4) | 1.1 | 4.9 (3.9–6.2) | 1.0 | 4.3 (3.4–5.4) | 2.1 | 9.2 (7.8–10.9) |
   Rural (n = 1222) | 0.7 | 7.8 (5.4–11.1) | 0.3 | 3.9 (2.4–6.1) | 0.3 | 3.7 (2.1–6.3) | 0.7 | 7.5 (5.2–10.9) |
Total national estimate (n = 3397) | 2.9 | 9.2 (7.9–10.7) | 1.5 | 4.6 (3.8–5.7) | 1.3 | 4.1 (3.3–5.1) | 2.7 | 8.7 (7.4–10.2) |